Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, type I
- 1 January 1993
- journal article
- case report
- Published by Hindawi Limited in Human Mutation
- Vol. 2 (2) , 85-93
- https://doi.org/10.1002/humu.1380020205
Abstract
Tyrosinemia type I is an autosomal recessive inborn error of metabolism caused by deficiency of the enzyme fumaryl acetoacetate hydrolase (FAH, EC 3.7.1.2.). We have used reverse transcription and the polymerize chain reaction to amplify the peptide coding region of the FAH cDNA from four patients with tyrosinemia type I. Chemical mismatch cleavage analysis and DNA sequencing were utilized to determine mutant alleles in all cases. A French Canadian patient was homozygous for a splice error mutation in the 3′ portion of the gene. A second patient, from a consanguineous pedigree in Iran, had the identical splice alteration. The third patient has a missense mutation, changing valine to glycine in codon 166. And finally two nonsense mutations in codons 357 and 364 were found in the fourth patient.Keywords
This publication has 22 references indexed in Scilit:
- Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenaseThe Lancet, 1992
- Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient.Journal of Clinical Investigation, 1992
- Nucleotide sequence of a cDNA encoding murine fumarylacetoacetate hydrolaseBiochemical Medicine and Metabolic Biology, 1992
- Liver transplantation in tyrosinaemia type 1: the dilemma of timing the operationActa Paediatrica, 1992
- Complete mutation detection using unlabeled chemical cleavageHuman Mutation, 1992
- Five mutations at the PAH locus account for almost 90% of PKU mutations in French-Canadians from eastern QuebecHuman Mutation, 1992
- Neurologic Crises in Hereditary TyrosinemiaNew England Journal of Medicine, 1990
- Direct Analysis of Single Nucleotide Variation in Human DNA and RNA Using In Situ Dot HybridizationDNA, 1989
- An Improved Method for Prenatal Diagnosis of Genetic Diseases by Analysis of Amplified DNA SequencesNew England Journal of Medicine, 1987
- Single-stranded DNA ‘blue’ T7 promoter plasmids: a versatile tandem promoter system for cloning and protein engineeringProtein Engineering, Design and Selection, 1986